|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pathology, Vanderbilt University Medical Center, Nashville, TN, USA
2 Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
3 Pathology, Vanderbilt University Medical Center, Nashville, TN, USA; Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
* To whom correspondence should be addressed. E-mail: barbara.meyrick{at}vanderbilt.edu.
This study examines the notion that Hsp90 binding to eNOS, nitric oxide (NO) and PI3K-Akt regulate angiopoietin-1 (Ang-1) induced angiogenesis in porcine coronary artery endothelial cells (PCAEC). Exposure to Ang-1 (250 ng/ml) for periods up to two hours resulted in a time-dependent increase in eNOS phosphorylation at Ser1177 that occurred by five minutes and peaked at 60 minutes. This was accompanied by a gradual increase in NO release. Ang-1 also led to stimulation of Hsp90 binding to eNOS and a significant increase in Akt phosphorylation. Thirty minutes pretreatment of cells with either 1µg/ml geldanamycin (a specific inhibitor of Hsp90) or 500nM wortmannin (a specific PI3 kinase inhibitor) significantly attenuated Ang-1 -stimulated eNOS phosphorylation and NO production. Exposure to Ang-1 caused an increase in endothelial cell migration, tube formation and sprouting from PCAEC spheroids and pharmacological blockage of Hsp90 function or inhibition of PI3K-Akt pathway completely abolished these effects. Inhibition of NOS by L-NAME (2.5 mM) also resulted in a significant decrease in Ang-1 induced angiogenesis. We conclude that stimulated Hsp90 binding to eNOS and activation of the PI3-Akt pathway contribute to Ang-1 induced eNOS phosphorylation, NO production and angiogenesis in PCAEC.
This article has been cited by other articles:
![]() |
M. Oubaha and J.-P. Gratton Phosphorylation of endothelial nitric oxide synthase by atypical PKC{zeta} contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro Blood, October 8, 2009; 114(15): 3343 - 3351. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Yuan, E. V. Khankin, S. A. Karumanchi, and S. M. Parikh Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium Mol. Cell. Biol., April 15, 2009; 29(8): 2011 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, D. Zhao, L. Qin, J. Li, and H. Zeng Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells J. Biol. Chem., December 5, 2008; 283(49): 34159 - 34167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-X. Chen and A. Stinnett Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice Diabetes, December 1, 2008; 57(12): 3335 - 3343. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ostergaard, E. Stankevicius, M. R. Andersen, Y. Eskildsen-Helmond, T. Ledet, M. J. Mulvany, and U. Simonsen Diminished NO release in chronic hypoxic human endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2894 - H2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brkovic, M. Pelletier, D. Girard, and M. G. Sirois Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation J. Leukoc. Biol., April 1, 2007; 81(4): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-X. Chen, H. Zeng, Q.-H. Tuo, H. Yu, B. Meyrick, and J. L. Aschner NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1664 - H1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Roberts, J. S. Isenberg, L. A. Ridnour, and D. A. Wink Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis Clin. Cancer Res., February 1, 2007; 13(3): 795 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-X. Chen, H. Zeng, M. L Lawrence, T. S. Blackwell, and B. Meyrick Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1563 - H1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P.J. Brindle, P. Saharinen, and K. Alitalo Signaling and Functions of Angiopoietin-1 in Vascular Protection Circ. Res., April 28, 2006; 98(8): 1014 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roviezzo, S. Tsigkos, A. Kotanidou, M. Bucci, V. Brancaleone, G. Cirino, and A. Papapetropoulos Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 738 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Chen, Y. Babichev, N. Rodrigues, D. Voskas, L. Ling, V. P. K. H. Nguyen, and D. J. Dumont Gene expression analysis of Tek/Tie2 signaling Physiol Genomics, July 14, 2005; 22(2): 257 - 267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |